Press release
Mumps Vaccine Market to grow further till USD 3,7 billion by 2032 | Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited
Global Mumps Vaccine Market report from Global Insight Services is the single authoritative source of intelligence on Mumps Vaccine Market. The report will provide you with analysis of impact of latest market disruptions such as Russia-Ukraine war and Covid-19 on the market. Report provides qualitative analysis of the market using various frameworks such as Porters' and PESTLE analysis. Report includes in-depth segmentation and market size data by categories, product types, applications, and geographies. Report also includes comprehensive analysis of key issues, trends and drivers, restraints and challenges, competitive landscape, as well as recent events such as M&A activities in the market.
Request free sample copy of this research study: https://www.globalinsightservices.com/request-sample/GIS24643
The immunizations used to prevent the mumps virus infection are known as mumps vaccines. The MMR vaccine, which is administered intravenously, is the vaccine of choice to protect against mumps infection. The live attenuated viruses of the three illnesses are used in this injection-based vaccine. Children under the age of 12 months and adults who are not at a high risk of exposure and transmission receive one dose of the MMR vaccination. Children between the ages of 2 and 18 as well as adults who run the risk of contracting the mumps are advised to have two doses of the vaccine.
Market Driver & Trends
Due to the large number of customers who are health-conscious, the pharmaceutical sector is growing and innovating to produce vaccines, which opens up opportunities for the mumps vaccine market to expand. The availability of increasing healthcare infrastructure, an increase in unmet healthcare demands, an increase in the occurrence of infectious diseases like the mumps diseases, and a surge in demand for mumps vaccines are all predicted to contribute to the growth of the mumps vaccine market.
Furthermore, the desire for better healthcare services, considerable government investments in enhancing the infrastructure for healthcare, and the growth of the medical tourism sector in emerging nations are all contributing to the significant growth of the global market for measles vaccines.
Read more about Mumps Vaccine Market here: https://www.globalinsightservices.com/reports/mumps-vaccine-market/
Global Mumps Vaccine Market Segmentation
By Age Group
• Pediatric
• Adult
By Distribution Channel
• Hospitals & Clinics
• Vaccination Centers
By Region
• North America
o The U.S.
o Canada
o Mexico
• Europe
o The UK
o Germany
o France
o Spain
o Rest of Europe
Get Customized Report as Per Your Requirement: https://www.globalinsightservices.com/request-customization/GIS24643
Major Players in the Global Mumps Vaccines Market
The key players studied in the report are MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited, Emergent BioSolutions, and GlaxoSmithKline among others.
Purchase your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS24643
With Global Insight Services, you receive:
• 10-year forecast to help you make strategic decisions
• In-depth segmentation which can be customized as per your requirements
• Free consultation with lead analyst of the report
• Excel data pack included with all report purchases
• Robust and transparent research methodology
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumps Vaccine Market to grow further till USD 3,7 billion by 2032 | Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited here
News-ID: 3000020 • Views: …
More Releases from Global Insight Services
Immuno Oncology Drugs Market Projected to Reach $634.1 Billion by 2034, Growing …
The Immuno Oncology Drugs Market is rapidly emerging as a transformative segment in the global healthcare industry. These drugs harness the body's immune system to identify and attack cancer cells, offering innovative treatment alternatives to traditional chemotherapy and radiation therapies. Immuno-oncology therapies include monoclonal antibodies, checkpoint inhibitors, cancer vaccines, and cell-based therapies such as CAR-T cells. The growth of this market is primarily driven by advancements in biotechnology, an improved…
GLP 1 Market Projected to Reach $221.8 Billion by 2034, Growing at 9% CAGR | Ove …
The GLP 1 Market is experiencing unprecedented growth, fueled by the rising prevalence of type 2 diabetes and obesity globally. GLP-1, or glucagon-like peptide-1 receptor agonists, represents a groundbreaking therapeutic class that improves insulin secretion, reduces glucagon production, and slows gastric emptying. These mechanisms not only enhance glycemic control but also support weight management, making GLP-1 therapies a preferred choice among healthcare providers and patients alike. Over the years, the…
Autonomous Bus Market to Expand to $11.6 Billion by 2034, Advancing at 18.8% CAG …
Market Overview
Autonomous Bus Market is revolutionizing the future of urban mobility through advanced automation technologies. Valued at $2.1 billion in 2024, the market is projected to reach $11.6 billion by 2034, expanding at a strong CAGR of 18.8%. This market focuses on the development and deployment of self-driving buses equipped with cutting-edge sensors, artificial intelligence, and vehicle-to-everything (V2X) communication systems. These buses are designed to improve road safety, enhance passenger…
Automotive Tire Market to Attain $976.7 Billion by 2034, Growing at 9.2% CAGR | …
Market Overview
Automotive Tire Market is experiencing remarkable growth as the industry embraces innovation, sustainability, and digital transformation. Valued at $406 billion in 2024, the market is projected to soar to $976.7 billion by 2034, reflecting a CAGR of 9.2%. This expansion is primarily driven by the surge in global vehicle production, growing consumer preference for durable and high-performance tires, and the increasing adoption of smart tire technologies. The Automotive Tire…
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, …
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greater…
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps vaccine is the most efficient way of preventing mumps viral infection in children and elderly population. Mumps vaccine is mainly administered in the form of combination vaccine, which offers resistance against measles, mumps, and rubella virus infections. The vaccine has no side effects; however, some cases may encounter very mild fever or rash. In addition, in some pediatric patients, mumps vaccine is given in the form of MMRV vaccine,…
Mumps Vaccine Market Analysis Growth Opportunities and Trends by Forecast To 203 …
Mumps Vaccine Market - Overview
Mumps is an infectious viral disease that results in swelling of the parotid salivary glands of the face. It is contagious and therefore, runs at a high risk of sterility when occurs in adult males. Mumps is usually characterized by muscle aches, headache, tiredness and fever, loss of appetite, and typical swelling of the one or more salivary glands.
Some other complications of mumps include infection in…
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren …
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leads…
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 – …
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well as…
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.…
